Genetic polymorphisms of molecules involved in host immune response to dengue virus infection

FEMS Immunology and Medical Microbiology

Volumn 66, Issue 2, 2012, Pages 134-146

  Fang, Xin ^a   Hu, Zhen ^a   Shang, Weilong ^a   Zhu, Junmin ^a   Xu, Chuanshan ^b   Rao, Xiancai ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Dengue virus; Genetics; Human immune; Molecules; Pathogenesis; Polymorphisms

Indexed keywords

CD209 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR IIA; GLYCOPROTEIN; HUMAN PLATELET SPECIFIC ANTIGEN; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 10; JANUS KINASE 1; MANNOSE BINDING LECTIN; MEMBRANE PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; DENDRITIC CELL; DENGUE; DENGUE VIRUS; DISEASE PREDISPOSITION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 84867735290     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2012.00995.x     Document Type: Short Survey

References (88)

1. Acioli-Santos B, Segat L, Dhalia R, Brito CA, Braga-Neto UM, Marques ET & Crovella S (2008) MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Hum Immunol 69: 122-128.
2. Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J & Schols D (2009) Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Virology 387: 67-75.
3. Alen MM, De Burghgraeve T, Kaptein SJ, Balzarini J, Neyts J & Schols D (2011) Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte derived dendritic cells. PLoS ONE 6: e21658.
4. Appanna R, Ponnampalavanar S, Lum Chai See L & Sekaran SD (2010) Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS ONE 5: e13029.
5. + T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J Infect Dis 197: 608-617.
6. Boonnak K, Slike BM, Burgess TH et al. (2008) Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J Virol 82: 3939-3951.
7. Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B & Marovich MA (2011) Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol 85: 1671-1683.
8. Bournazos S, Woof JM, Hart SP & Dransfield I (2009) Functional and clinical consequences of Fc receptor polymorphic and copy number variants. Clin Exp Immunol 157: 244-254.
9. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, Bozza PT & Kubelka CF (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFNgamma as predictive factors for severity. BMC Infect Dis 8: 86.
10. Brown MG, King CA, Sherren C, Marshall JS & Anderson R (2006) A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol 80: 1242-1250.
11. Castro JE, Vado-Solis I, Perez-Osorio C & Fredeking TM (2011) Modulation of cytokine and cytokine receptor/antagonist by treatment with doxycycline and tetracycline in patients with dengue fever. Clin Dev Immunol 2011: 370872.
12. Chang SC, Momburg F, Bhutani N & Goldberg AL (2005) The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a 'molecular ruler' mechanism. P Natl Acad Sci USA 102: 17107-17112.
13. + T cell polarization by dengue virus-infected dendritic cells. J Infect Dis 203: 1763-1774.
14. Chaturvedi UC, Elbishbishi EA, Agarwal R & Mustafa AS (2001) Cytotoxic factor- autoantibodies: possible role in the pathogenesis of dengue haemorrhagic fever. FEMS Immunol Med Microbiol 30: 181-186.
15. Chaturvedi UC, Nagar R & Shrivastava R (2006) Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol Med Microbiol 47: 155-166.
16. Chen RF, Liu JW, Yeh WT, Wang L, Chang JC, Yu HR, Cheng JT & Yang KD (2005) Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 44: 43-50.
17. Chen RF, Wang L, Cheng JT, Chuang H, Chang JC, Liu JW, Lin IC & Yang KD (2009) Combination of CTLA-4 and TGFβ1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak. Clin Immunol 131: 404-409.
18. Chuang YC, Lei HY, Liu HS, Lin YS, Fu TF & Yeh TM (2011) Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability. Cytokine 54: 222-231.
19. Coffey LL, Mertens E, Brehin AC, Fernandez-Garcia MD, Amara A, Després P & Sakuntabhai A (2009) Human genetic determinants of dengue virus susceptibility. Microbes Infect 11: 143-156.
20. De Carvalho Bittencourt M, Martial J, Cabié A, Thomas L & Césaire R (2012) Decreased peripheral dendritic cell numbers in dengue virus infection. J Clin Immunol 32: 161-172.
21. De la C Sierra B, Kourí G & Guzmán MG (2007) Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152: 533542.
22. Dejnirattisai W, Jumnainsong A, Onsirisakul N et al. (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328: 745-748.
23. De-Oliveira-Pinto LM, Gandini M, Freitas LP, Siqueira MM, Marinho CF, Setúbal S, Kubelka CF, Cruz OG & Oliveira SA (2012) Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1β and CCL2/MCP-1 in dengue fever and parvovirosis. Mem Inst Oswaldo Cruz 107: 48-56.
24. Desprès P, Sakuntabhai A & Julier C (2005) A variant in the CD209 promoter is associated with severity of dengue disease. Med Sci (Paris) 21: 905-906.
25. Endy TP, Anderson KB, Nisalak A, Yoon IK, Green S, Rothman AL, Thomas SJ, Jarman RG, Libraty DH & Gibbons RV (2011) Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl Trop Dis 5: e975.
26. Falconar AK & Martinez F (2011) The NS1 glycoprotein can generate dramatic antibody- enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease. PLoS ONE 6: e21024.
27. Feldmann M (2008) Many cytokines are very useful therapeutic targets in disease. J Clin Invest 118: 3533-3536.
28. Fernández-Mestre MT, Gendzekhadze K, Rivas-Vetencourt P & Layrisse Z (2004) TNF-alpha- 308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64: 469-472.
29. Fernández-Mestre M, Sánchez K, Balbás O, Gendzekhzadze K, Ogando V, Cabrera M & Layrisse Z (2009) Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases. Hum Immunol 70: 532-535.
30. Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon IK, Jarman RG, Green S, Rothman AL & Cummings DA (2010) Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4: e617.
31. Fuchs A, Lin TY, Beasley DW, Stover CM, Schwaeble WJ, Pierson TC & Diamond MS (2010) Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin. Cell Host Microbe 8: 186-195.
32. García G, Sierra B, Pérez AB et al. (2010) Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcγRIIa polymorphism. Am J Trop Med Hyg 82: 1153-1156.
33. García G, Del Puerto F, Pérez AB, Sierra B, Aguirre E, Kikuchi M, Sánchez L, Hirayama K & Guzmán MG (2011) Association of MICA and MICB alleles with symptomatic dengue infection. Hum Immunol 72: 904-907.
34. García-Trejo AR, Falcón-Lezama JA, Juárez-Palma L, Granados J, Zúñiga-Ramos J, Rangel H, Barquera R, Vargas-Alarcón G & Ramos C (2011) Tumor necrosis factor alpha promoter polymorphisms in Mexican patients with dengue fever. Acta Trop 120: 67-71.
35. Green S & Rothman A (2006) Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 19: 429-436.
36. Gunther VJ, Putnak R, Eckels KH, Mammen MP, Scherer JM, Lyons A, Sztein MB & Sun W (2011) A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine 29: 3895-3904.
37. Guzman MG & Vazquez S (2010) The complexity of antibody-dependent enhancement of dengue virus infection. Viruses 2: 2649-2662.
38. Guzman MG, Halstead SB, Artsob H et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7-S16.
39. Halstead SB & O'Rourke EJ (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265: 739-741.
40. Halstead SB, Nimmannitya S & Cohen SN (1970) Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 42: 311-328.
41. Hatch S, Endy TP, Thomas S, Mathew A, Potts J, Pazoles P, Libraty DH, Gibbons R & Rothman AL (2011) Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. J Infect Dis 203: 1282-1291.
42. Hershkovitz O, Zilka A, Bar-Ilan A, Abutbul S, Davidson A, Mazzon M, Kümmerer BM, Monsoengo A, Jacobs M & Porgador A (2008) Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells. J Virol 82: 7666-7676.
43. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC & Yeh TM (2000) Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 63: 71-75.
44. Ip WK, Takahashi K, Ezekowitz RA & Stuart LM (2009) Mannose-binding lectin and innate immunity. Immunol Rev 230: 9-21.
45. Jakubowska-Pietkiewicz E, Młynarski W, Klich I, Fendler W & Chlebna-Sokół D (2012) Vitamin D receptor gene variability as a factor influencing bone mineral density in pediatric patients. Mol Biol Rep 39: 6243-6250.
46. Jiang Z, Feng X, Zhang W, Gao F, Ling Q, Zhou L, Xie H, Chen Q & Zheng S (2007) Recipient cytotoxic T lymphocyte antigen-4 + 49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Liver Int 27: 1202-1208.
47. Khattri R, Auger JA, Griffin MD, Sharpe AH & Bluestone JA (1999) Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. J Immunol 162: 5784-5791.
48. Kilpatrick DC (2002) Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 1572: 401-413.
49. Kontny U, Kurane I & Ennis FA (1988) Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol 62: 3928-3933.
50. Kou Z, Lim JY & Beltramello M (2011) Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes. Virology 410: 240-247.
51. Kourí G, Guzmán MG, Valdés L, Carbonel I, del Rosario D, Vazquez S, Laferté J, Delgado J & Cabrera MV (1998) Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis 4: 89-92.
52. Kurane I (2007) Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis 30: 329-340.
53. Lobigs M, Blanden RV & Müllbacher A (1996) Flavivirus-induced up-regulation of MHC class I antigens: implications for the induction of CD81 T-cell-mediated autoimmunity. Immunol Rev 152: 5-19.
54. Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, White NJ, Day NP, Farrar J & Hill AV (2001) Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 184: 1369-1373.
55. Loke H, Bethell D, Phuong CX, Day N, White N, Farrar J & Hill A (2002) Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 67: 102-106.
56. Lorente E, Infantes S, Barnea E et al. (2012) Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells. J Virol 86: 527-541.
57. Marcinkowska EA (2001) Run for a membrane vitamin D receptor. Biol Signals Recept 10: 341-349.
58. Mathew A & Rothman AL (2008) Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 225: 300-313.
59. Moi ML, Lim CK, Kotaki A, Takasaki T & Kurane I (2010) Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA. J Virol Methods 163: 205-209.
60. Mustafa AS, Elbishbishi EA, Agarwal R & Chaturvedi UC (2001) Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 30: 229-233.
61. Nimmerjahn F & Ravetch JV (2008) Fcγ receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47.
62. Oliveira RA, Oshiro M, Hirata MH, Hirata RD, Ribeiro GS, Medeiros TM & de O Barretto OC (2009) A novel point mutation in a class IV glucose-6-phosphate dehydrogenase variant (G6PD São Paulo) and polymorphic G6PD variants in São Paulo State, Brazil. Genet Mol Biol 32: 251-254.
63. Palaniyar N, Nadesalingam J, Clark H, Shih MJ, Dodds AW & Reid KB (2004) Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin. J Biol Chem 279: 32728-32736.
64. Perez AB, Sierra B, Garcia G, Aguirre E, Babel N, Alvarez M, Sanchez L, Valdes L, Volk HD & Guzman MG (2010) Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. Hum Immunol 71: 1135-1140.
65. Saito M, Oishi K, Inoue S et al. (2004) Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol 138: 299-303.
66. Schieffelin JS, Costin JM, Nicholson CO, Orgeron NM, Fontaine KA, Isern S, Michael SF & Robinson JE (2010) Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol J 7: 28.
67. Selvaraj P, Alagarasu K, Swaminathan S, Harishankar M & Narendran G (2009) CD209 gene polymorphisms in South Indian HIV and HIV-TB patients. Infect Genet Evol 9: 256-262.
68. Shang W, Liu J, Yang J, Hu Z & Rao X (2012) Dengue virus-like particles: construction and application. Appl Microbiol Biotechnol 94: 39-46.
69. Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR & Harris E (2004) Interferon- dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol 78: 2701-2710.
70. Silva LK, Blanton RE, Parrado AR et al. (2010) Dengue hemorrhagic fever is associated with polymorphisms in JAK1. Eur J Hum Genet 18: 1221-1227.
71. Soundravally R & Hoti SL (2007) Immunopathogenesis of dengue hemorrhagic fever and shock syndrome: Role of TAP and HPA gene polymorphism. Hum Immunol 68: 973-979.
72. Soundravally R & Hoti SL (2008a) Significance of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in susceptibility to dengue viral infection. J Clin Immunol 28: 256-262.
73. Soundravally R & Hoti SL (2008b) Polymorphisms of the TAP 1 and 2 Gene may influence clinical outcome of primary dengue viral infection. Scand J Immunol 67: 618-625.
74. Stein DA, Perry ST, Buck MD et al. (2011) Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence. J Virol 85: 10154-10166.
75. Stephens HA (2010) HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 338: 99-114.
76. Sunder SR, Hanumanth SR, Gaddam S, Jonnalagada S & Valluri VL (2011) Association of TAP 1 and 2 gene polymorphisms with human immunodeficiency virus-tuberculosis co-infection. Hum Immunol 72: 908-911.
77. Tolfvenstam T, Lindblom A, Schreiber MJ, Ling L, Chow A, Ooi EE & Hibberd ML (2011) Characterization of early host responses in adults with dengue disease. BMC Infect Dis 11: 209.
78. Turner MW (1996) Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 17: 532-540.
79. Ubol S & Halstead SB (2010) How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vac Immunol 17: 1829-1835.
80. Vasconcelos LR, Fonseca JP, do Carmo RF, de Mendonça TF, Pereira VR, Lucena-Silva N, Pereira LM, Moura P & Cavalcanti Mdo S (2011) Mannose-binding lectin serum levels in patients with leprosy are influenced by age and MBL2 genotypes. Int J Infect Dis 15: e551-e557.
81. Vejbaesya S, Luangtrakool P, Luangtrakool K et al. (2009) TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis 199: 1442-1448.
82. Wang S, He R, Patarapotikul J, Innis BL & Anderson R (1995) Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 213: 254-257.
83. Wang L, Chen RF, Liu JW, Lee IK, Lee CP, Kuo HC, Huang SK & Yang KD (2011) DC-SIGN (CD209) Promoter -336 A/G Polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation. PLoS Negl Trop Dis 5: e934.
84. Wichukchinda N, Kitamura Y, Rojanawiwat A et al. (2007) The polymorphisms in DC-SIGN affect susceptibility to HIV type 1 infection. AIDS Res Hum Retrovir 23: 686-692.
85. World Health Organization, WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases - Dengue and dengue haemorrhagic fever. http://www.who.int/csr/resources/publications/dengue/CSR_ISR_2000_1/en/index6.html (accessed on June 2012).
86. Yang J, Zhang J, Chen W et al. (2012) Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli. Can J Microbiol 58: 369-380.
87. + T cells. J Immunol 182: 4865-4873.
88. Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HA, Chandanayingyong D, Nisalak A, Ennis FA & Rothman AL (2002) T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 168: 5959-5965.